| Acne |
No |
| Active substance |
Mycophenolate Mofetil |
| Also known as |
MMF |
| Aromatization |
No |
| Blood pressure |
Typically has no direct effect on blood pressure |
| Chemical name |
2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
| Dosage (medical) |
Typically 1g orally twice a day |
| Dosage (sports) |
Not applicable as it does not enhance athletic performance |
| Effects |
Prevents organ rejection in transplant patients |
| Formula |
C23H31NO7 |
| Half-life |
Approximately 17.9 hours (for the active metabolite mycophenolic acid) |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Blood levels of mycophenolic acid may be monitored to adjust dose |
| Main action |
Inhibits inosine monophosphate dehydrogenase, leading to suppression of lymphocyte proliferation |
| Side effects |
Gastrointestinal disturbances, increased risk of infections, leukopenia, anemia |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Immunosuppressant, specifically a prodrug of mycophenolic acid |
| Trade name |
CellCept |
| Use in sports |
Not typically used in sports due to its immunosuppressive effects |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
Roche |
